Glycosylation-modified antigens as an inverse vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy
S. Cao, C. D. Maulloo, M. M. Raczy, M. Sabados, A. J. Slezak, M. Nguyen, A. Solanki, R. P. Wallace, H.-N. Shim, D. S. Wilson, J. A. Hubbell
This paper develops a glycosylation-modified antigen vaccine platform that prevents anaphylaxis in a cow's milk allergy mouse model by inducing antigen-specific non-responsiveness.
bioRxiv · Mar 23, 2023Bioengineering